Microbiome Sequencing Data
Buy and sell microbiome sequencing data data. Gut, skin, oral microbiome profiles — microbiome AI is a $2B market and it needs diverse population data.
No listings currently in the marketplace for Microbiome Sequencing Data.
Find Me This Data →Overview
What Is Microbiome Sequencing Data?
Microbiome sequencing data involves the analysis of microbial communities inhabiting various environments, particularly the human body including gut, skin, and oral microbiomes. These specialized procedures identify and profile microbial composition, diversity, and functional potential using advanced sequencing technologies such as 16S rRNA gene sequencing and shotgun metagenomics. The global microbiome sequencing services market reached USD 3.05 billion in 2025 and is experiencing rapid expansion driven by declining sequencing costs, increasing adoption of personalized medicine, and growing regulatory requirements across healthcare, agriculture, and food safety sectors. This data is critical for advancing research in disease mechanisms, drug efficacy prediction, and therapeutic development, particularly in microbiome-based treatments like fecal microbiota transplantation (FMT).
Market Data
USD 3.05 billion
Global Market Size (2025)
Source: IMARC Group
USD 12.13 billion
Projected Market Size (2034)
Source: IMARC Group
16.09%
Market CAGR (2026–2034)
Source: IMARC Group
49.3% of DTC market
16S rRNA Market Share (2025)
Source: DataIntelo
Under $50 per sample
16S rRNA Sequencing Cost
Source: DataIntelo
Who Uses This Data
What AI models do with it.do with it.
Personalized Medicine & Therapeutics
Healthcare providers and patients use microbiome sequencing to tailor treatments, optimize probiotic regimens, guide dietary recommendations, and predict drug efficacy for individual patients. Microbiome data is essential for achieving better treatment outcomes and minimizing adverse effects.
Pharmaceutical & Biotechnology R&D
Pharmaceutical and biotechnology companies leverage microbiome sequencing for drug discovery, clinical validation of microbiome-based therapeutics, and understanding how individual microbiomes affect treatment response and efficacy.
Food Safety & Agriculture
Food industry and agricultural organizations use microbiome sequencing to monitor and improve food safety, identify potential pathogens, assess spoilage organisms, and ensure sustainable farming practices while meeting regulatory compliance standards.
Academic & Clinical Research
Research institutions and academic centers conduct microbiome studies to advance understanding of disease mechanisms, ecosystem resilience, and human health outcomes across diverse populations.
What Can You Earn?
What it's worth.worth.
Individual Consumer Data (DTC)
Varies
Direct-to-consumer testing providers typically charge consumers $100–$300 per test; data acquisition costs depend on collection method and sequencing technology used (16S rRNA under $50 per sample at scale).
Research & Institutional Data
Varies
Sequencing services for research institutions and pharmaceutical companies command premium pricing based on sample volume, sequencing depth, turnaround time, and bioinformatics analysis requirements.
Clinical & Therapeutic Data
Varies
Data from patient populations for clinical validation or therapeutic development generates higher value due to regulatory significance and clinical relevance.
What Buyers Expect
What makes it valuable.valuable.
Data Privacy & Security Compliance
Microbiome data is recognized as highly sensitive personal health information. Buyers expect robust data protection, explicit consent management, and compliance with healthcare privacy regulations. Consumer research shows 44% of users express significant concern about third-party data sharing.
Sample Quality & Chain of Custody
Proper sample collection, processing, nucleic acid extraction, and documentation of sample handling procedures are critical. Buyers require validated protocols and clear provenance tracking to ensure data integrity and reproducibility.
Sequencing Depth & Accuracy
Buyers expect sufficient sequencing coverage to reliably detect and quantify microbial taxa. Accuracy depends on sequencing technology (16S rRNA vs. shotgun metagenomics), read quality, and bioinformatics pipeline validation.
Population Diversity & Representation
The microbiome AI market requires diverse population data across different geographies, demographics, and health statuses to train robust models and ensure clinical applicability across varied patient populations.
Regulatory & Clinical Validation
For clinical or therapeutic applications, buyers require data from validated protocols, documented quality assurance practices, and compliance with growing regulatory requirements in healthcare and food safety sectors.
Companies Active Here
Who's buying.buying.
Microbiome sequencing services provider offering 16S and metagenomic analysis for research and clinical applications.
Provider of microbiome sequencing services and sample processing solutions for research, diagnostics, and therapeutic development.
Microbiome sequencing services company focusing on diverse microbiome profiling across multiple body sites.
Specializes in clinical microbiome sequencing and diagnostics for personalized medicine and therapeutic applications.
Microbiome sequencing services provider offering 16S rRNA and metagenomic analysis for diverse research and clinical applications.
FAQ
Common questions.questions.
What sequencing technologies are most commonly used in microbiome analysis?
16S rRNA sequencing dominates the direct-to-consumer market with 49.3% share in 2025, prized for cost efficiency (under $50 per sample) and rapid turnaround. Shotgun metagenomic sequencing is the fastest-growing technology, expanding at 16.8% CAGR (2026–2034), offering superior resolution as costs decline. Whole genome sequencing accounts for approximately 11.4% of revenues and serves premium consumer segments.
How much has microbiome sequencing cost decreased?
Costs have declined dramatically: whole-genome sequencing fell from approximately $10,000 per sample in 2010 to under $200 in 2025, while 16S rRNA sequencing costs for microbiome profiling dropped below $50 per sample at commercial scale. The cost-per-gigabase of sequencing declined by approximately 18% annually between 2020 and 2025, driven by advances in Illumina and Oxford Nanopore sequencing platforms.
Which microbiome segments represent the largest market opportunity?
Gut microbiome holds the largest share at 58.3% of the direct-to-consumer market in 2025, followed by oral and skin microbiomes. All segments are experiencing growth driven by personalized medicine adoption, but competitive saturation in the gut segment may compress margins for undifferentiated providers.
What are the primary data privacy concerns for microbiome data?
Microbiome data is increasingly recognized as highly sensitive personal health information. A 2025 survey found that 44% of consumers expressed significant concern about third-party sharing of their microbiome data by direct-to-consumer providers, highlighting the need for robust data protection, explicit consent management, and compliance with healthcare privacy regulations.
Sell yourmicrobiome sequencingdata.
If your company generates microbiome sequencing data, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation